| Non-alcoholic fatty liver disease and diabetes JM Hazlehurst, C Woods, T Marjot, JF Cobbold, JW Tomlinson Metabolism 65 (8), 1096-1108, 2016 | 595 | 2016 |
| Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus AE Hogan, G Gaoatswe, L Lynch, MA Corrigan, C Woods, J O’Connell, ... Diabetologia 57, 781-784, 2014 | 209 | 2014 |
| Glucocorticoids and non-alcoholic fatty liver disease CP Woods, JM Hazlehurst, JW Tomlinson The Journal of steroid biochemistry and molecular biology 154, 94-103, 2015 | 178 | 2015 |
| Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol CP Woods, N Argese, M Chapman, C Boot, R Webster, V Dabhi, ... European journal of endocrinology 173 (5), 633-642, 2015 | 150 | 2015 |
| The natural history of surgically treated but radiotherapy‐naïve nonfunctioning pituitary adenomas EP O’Sullivan, C Woods, N Glynn, LA Behan, R Crowley, P O’Kelly, ... Clinical endocrinology 71 (5), 709-714, 2009 | 147 | 2009 |
| Medical therapy in acromegaly M Sherlock, C Woods, MC Sheppard Nature Reviews Endocrinology 7 (5), 291-300, 2011 | 95 | 2011 |
| Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection D O'Shea, M Corrigan, MR Dunne, R Jackson, C Woods, G Gaoatswe, ... International journal of obesity 37 (11), 1510-1513, 2013 | 88 | 2013 |
| Baseline morning cortisol level as a predictor of pituitary–adrenal reserve: a comparison across three assays E Sbardella, AM Isidori, CP Woods, N Argese, JW Tomlinson, B Shine, ... Clinical endocrinology 86 (2), 177-184, 2017 | 68 | 2017 |
| The short Synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function R Pofi, C Feliciano, E Sbardella, N Argese, CP Woods, AB Grossman, ... The Journal of Clinical Endocrinology & Metabolism 103 (8), 3050-3059, 2018 | 57 | 2018 |
| Somnolence in adult craniopharyngioma patients is a common, heterogeneous condition that is potentially treatable RK Crowley, C Woods, M Fleming, B Rogers, LA Behan, EP O’sullivan, ... Clinical endocrinology 74 (6), 750-755, 2011 | 48 | 2011 |
| Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT) CP Woods, M Corrigan, L Gathercole, A Taylor, B Hughes, G Gaoatswe, ... The Journal of Clinical Endocrinology & Metabolism 100 (4), 1434-1444, 2015 | 46 | 2015 |
| Obesity in adults: a 2022 adapted clinical practice guideline for Ireland C Breen, J O’Connell, J Geoghegan, D O’Shea, S Birney, L Tully, ... Obesity Facts 15 (6), 736-752, 2022 | 35 | 2022 |
| Peripheral inflammation and cognitive performance in middle-aged adults with and without type 2 diabetes: results from the ENBIND study AH Dyer, L McKenna, I Batten, K Jones, M Widdowson, J Dunne, ... Frontiers in Aging Neuroscience 12, 605878, 2020 | 25 | 2020 |
| Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas LA Behan, EP O’Sullivan, N Glynn, C Woods, RK Crowley, TK Tun, ... Journal of endocrinological investigation 36, 508-514, 2013 | 24 | 2013 |
| Association between vitamin D status and physical function in the severely obese T Ahern, A Khattak, E O'malley, C Dunlevy, M Kilbane, C Woods, ... The Journal of Clinical Endocrinology & Metabolism 99 (7), E1327-E1331, 2014 | 22 | 2014 |
| The dehydrogenase hypothesis C Woods, JW Tomlinson Glucocorticoid Signaling: From Molecules to Mice to Man, 353-380, 2015 | 19 | 2015 |
| Risk of diabetes insipidus after pituitary surgery C Woods, CJ Thompson Expert review of endocrinology & metabolism 3 (1), 23-27, 2008 | 17 | 2008 |
| Cognitive performance in midlife type 2 diabetes: results from the ENBIND study AH Dyer, L McKenna, G Gamage, NM Bourke, I Killane, M Widdowson, ... Diabetic Medicine 38 (6), e14412, 2021 | 16 | 2021 |
| The prevalence and incidence of thyroid dysfunction in patients with diabetes-a longitudinal follow-up study RM Tudor, A Garrahy, CP Woods, RK Crowley, WT Tormey, D Smith, ... Irish Journal of Medical Science (1971-) 189, 171-175, 2020 | 12 | 2020 |
| Co-administration of 5α-reductase inhibitors worsens the adverse metabolic effects of prescribed glucocorticoids N Othonos, T Marjot, C Woods, JM Hazlehurst, N Nikolaou, R Pofi, ... The Journal of Clinical Endocrinology & Metabolism 105 (9), e3316-e3328, 2020 | 10 | 2020 |
Jeremy TomlinsonUniversity of Oxford在 ocdem.ox.ac.uk 的电子邮件经过验证
